Lecciones aprendidas a partir de brotes anteriores
References
Adams, J. L., Shelley, K., & Nicol, M. R. (2019). Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 39(4), 486-500.
Centers for Disease Control and Prevention. (2016). History of smallpox.
Centers for Disease Control and Prevention. (2014). Monitoring the impact of varicella vaccination.
de Quadros, C. A. (2002). History and prospects for disease eradication. Institute of Medicine (US) Forum on Emerging Infections. National Academies Press.
Heymann, D. L., & Rodier, G. (2004). SARS: lessons from a new disease. Learning from SARS: Preparing for the next disease outbreak, 234-245.
Hulo C, de Castro E, Masson P, Bougueleret L, Bairoch A, Xenarios I, Le Mercier P. (2011) "ViralZone: a knowledge resource to understand virus diversity. Nucleic Acids Res. 39(Database issue):D576-82.
Roush, S. W., Murphy, T. V., & Vaccine-Preventable Disease Table Working Group. (2007). Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Jama, 298(18), 2155-2163.
Thèves, C., Crubézy, E., & Biagini, P. (2016). History of smallpox and its spread in human populations. Paleomicrobiology of Humans, 161-172.
World Health Organization. (2018). Managing epidemics: key facts about major deadly diseases. World Health Organization. https://www.who.int/emergencies/diseases/managing-epidemics-interactive.pdf